These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30325181)

  • 21. Emerging use of stem cells in regenerative medicine.
    Teo AK; Vallier L
    Biochem J; 2010 Apr; 428(1):11-23. PubMed ID: 20423328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges in deriving and utilizing stem cell-derived endothelial cells for regenerative medicine: a key issue in clinical therapeutic applications.
    Jalil RA; Neng LC; Kofidis T
    J Stem Cells; 2011; 6(2):93-9. PubMed ID: 22997849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
    Amabile G; Meissner A
    Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Biomedical Applications on Stem Cell Therapy: A Brief Overview.
    Agrawal M; Alexander A; Khan J; Giri TK; Siddique S; Dubey SK; Ajazuddin ; Patel RJ; Gupta U; Saraf S; Saraf S
    Curr Stem Cell Res Ther; 2019; 14(2):127-136. PubMed ID: 30280676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M; Tohyama S; Fukuda K
    Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling epilepsy with pluripotent human cells.
    Muotri AR
    Epilepsy Behav; 2009 Jan; 14 Suppl 1():81-5. PubMed ID: 18845273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced pluripotent stem (iPS) cells from human fetal stem cells.
    Guillot PV
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():112-20. PubMed ID: 26427551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult stem cells: hopes and hypes of regenerative medicine.
    Dulak J; Szade K; Szade A; Nowak W; Józkowicz A
    Acta Biochim Pol; 2015; 62(3):329-37. PubMed ID: 26200199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human and Pig Pluripotent Stem Cells: From Cellular Products to Organogenesis and Beyond.
    Xuan Y; Petersen B; Liu P
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.
    Lee H; Park J; Forget BG; Gaines P
    Regen Med; 2009 Sep; 4(5):759-69. PubMed ID: 19761400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The advancement of human pluripotent stem cell-derived therapies into the clinic.
    Thies RS; Murry CE
    Development; 2015 Sep; 142(18):3077-84. PubMed ID: 26395136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial (Thematic Issue: Current Status of Stem Cell Research in Regenerative Medicine - How Close We Are from Bench Side to Bedside?).
    Feng YM
    Curr Stem Cell Res Ther; 2016; 11(7):532. PubMed ID: 27640916
    [No Abstract]   [Full Text] [Related]  

  • 35. Generation of human organs in pigs via interspecies blastocyst complementation.
    Wu J; Platero Luengo A; Gil MA; Suzuki K; Cuello C; Morales Valencia M; Parrilla I; Martinez CA; Nohalez A; Roca J; Martinez EA; Izpisua Belmonte JC
    Reprod Domest Anim; 2016 Oct; 51 Suppl 2():18-24. PubMed ID: 27762052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine.
    Ogura F; Wakao S; Kuroda Y; Tsuchiyama K; Bagheri M; Heneidi S; Chazenbalk G; Aiba S; Dezawa M
    Stem Cells Dev; 2014 Apr; 23(7):717-28. PubMed ID: 24256547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuated Innate Immunity in Embryonic Stem Cells and Its Implications in Developmental Biology and Regenerative Medicine.
    Guo YL; Carmichael GG; Wang R; Hong X; Acharya D; Huang F; Bai F
    Stem Cells; 2015 Nov; 33(11):3165-73. PubMed ID: 26086534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification, characterization and biological significance of very small embryonic-like stem cells (VSELs) in regenerative medicine.
    Feng G; Cui J; Zheng Y; Han Z; Xu Y; Li Z
    Histol Histopathol; 2012 Jul; 27(7):827-33. PubMed ID: 22648539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
    Duelen R; Sampaolesi M
    EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shifting gears from embryonic to very small embryonic-like stem cells for regenerative medicine.
    Bhartiya D
    Indian J Med Res; 2017 Jul; 146(1):15-21. PubMed ID: 29168456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.